Understanding TSC1: Potential Drug Targets for A Variety of Diseases

Target Name: TSC1

NCBI ID: G7248

Understanding TSC1: Potential Drug Targets for A Variety of Diseases

Tuberous sclerosis 1 (TSC1) is a protein that is expressed in a variety of tissues throughout the body, including the brain, heart, lungs, and liver. It is a member of theulin family and is involved in a number of cellular processes, including cell signaling, DNA replication, and stress response.

TSC1 has been identified as a potential drug target for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in these conditions has led to a growing interest in studying its biology and developing new treatments.

One of the key challenges in studying TSC1 is its complex structure and biology. Because it is a protein, it is difficult to study and manipulate in the lab. Researchers have identified a number of potential drug targets based on its unique structure and function, but much more work is needed to fully understand its role in the body and how it can be targeted by drugs.

TSC1 is involved in a number of cellular processes that are important for the health and function of many different tissues. One of its key functions is in cell signaling. TSC1 plays a role in the formation of tight junctions, which are the barriers that separate cells from the surrounding tissue. These barriers help to maintain the integrity of the tissue and keep cells from coming into contact with harmful substances.

TSC1 is also involved in DNA replication, which is a critical process for the growth and development of all living organisms. When DNA replication occurs, TSC1 helps to ensure that the copies of the DNA are made accurately and completely. This is important for the development and growth of new tissues and organs, and is also critical for the repair of damaged DNA.

In addition to its role in cell signaling and DNA replication, TSC1 is also involved in stress response. When the body experiences stress, TSC1 helps to regulate the signaling pathways that are involved in the stress response. This is important for maintaining the stability and integrity of the body's tissues and organs, and is critical for the survival of the organism.

TSC1 has been identified as a potential drug target for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in these conditions has led to a growing interest in studying its biology and developing new treatments.

One of the key challenges in studying TSC1 is its complex structure and biology. Because it is a protein, it is difficult to study and manipulate in the lab. Researchers have identified a number of potential drug targets based on its unique structure and function, but much more work is needed to fully understand its role in the body and how it can be targeted by drugs.

In conclusion, TSC1 is a protein that is expressed in a variety of tissues throughout the body and is involved in a number of cellular processes that are important for the health and function of many different tissues. Its complex structure and biology make it difficult to study and manipulate in the lab, but its potential as a drug target for a variety of diseases makes it an important area of research. Further studies are needed to fully understand its role in the body and how it can be targeted by drugs.

Protein Name: TSC Complex Subunit 1

Functions: In complex with TSC2, inhibits the nutrient-mediated or growth factor-stimulated phosphorylation of S6K1 and EIF4EBP1 by negatively regulating mTORC1 signaling (PubMed:12271141, PubMed:28215400). Seems not to be required for TSC2 GAP activity towards RHEB (PubMed:15340059). Implicated as a tumor suppressor. Involved in microtubule-mediated protein transport, but this seems to be due to unregulated mTOR signaling (By similarity). Acts as a co-chaperone for HSP90AA1 facilitating HSP90AA1 chaperoning of protein clients such as kinases, TSC2 and glucocorticoid receptor NR3C1 (PubMed:29127155). Increases ATP binding to HSP90AA1 and inhibits HSP90AA1 ATPase activity (PubMed:29127155). Competes with the activating co-chaperone AHSA1 for binding to HSP90AA1, thereby providing a reciprocal regulatory mechanism for chaperoning of client proteins (PubMed:29127155). Recruits TSC2 to HSP90AA1 and stabilizes TSC2 by preventing the interaction between TSC2 and ubiquitin ligase HERC1 (PubMed:16464865, PubMed:29127155)

More Common Targets